Identifying Disease Associated miRNAs Based on Protein Domains
暂无分享,去创建一个
[1] Xing-Ming Zhao,et al. Predicting drug targets based on protein domains. , 2012, Molecular bioSystems.
[2] Lewis R. Roberts,et al. Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.
[3] Yufei Huang,et al. Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.
[4] Hailin Chen,et al. Similarity-based methods for potential human microRNA-disease association prediction , 2013, BMC Medical Genomics.
[5] Xantha Karp,et al. Encountering MicroRNAs in Cell Fate Signaling , 2005, Science.
[6] Yuan Wang,et al. [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression]. , 2014, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.
[7] R. Jiang,et al. Prioritisation of associations between protein domains and complex diseases using domain-domain interaction networks. , 2010, IET systems biology.
[8] Rongguo Li,et al. Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathway , 2015, OncoTargets and therapy.
[9] Xiaodong Gu,et al. miR-449b inhibits the proliferation of SW1116 colon cancer stem cells through downregulation of CCND1 and E2F3 expression. , 2013, Oncology reports.
[10] Teresa M. Przytycka,et al. DOMINE: a database of protein domain interactions , 2007, Nucleic Acids Res..
[11] Xiao-Qian Zhao,et al. Lack of Association of MiR-34b/c Polymorphism (rs4938723) with Hepatocellular Carcinoma: A Meta-Analysis , 2013, PloS one.
[12] Xing Chen,et al. RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.
[13] Yang Li,et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..
[14] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[15] R. Xiang,et al. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer. , 2013, Biochimica et biophysica acta.
[16] Cheng Wang,et al. YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression , 2014, Oncogene.
[17] C. Burge,et al. Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.
[18] L. Holm,et al. The Pfam protein families database , 2005, Nucleic Acids Res..
[19] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[20] Peter B. McGarvey,et al. Infrastructure for the life sciences: design and implementation of the UniProt website , 2009, BMC Bioinformatics.
[21] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[22] Yuanqing Ye,et al. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. , 2008, Cancer research.
[23] Q. Cui,et al. An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.
[24] R. Jiang. Walking on multiple disease-gene networks to prioritize candidate genes. , 2015, Journal of molecular cell biology.
[25] J. Aster,et al. The double-edged sword of Notch signaling in cancer. , 2012, Seminars in cell & developmental biology.
[26] Rui Jiang,et al. Pinpointing disease genes through phenomic and genomic data fusion , 2015, BMC Genomics.
[27] E. Miska,et al. How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.
[28] Xing-Ming Zhao,et al. Identifying cancer-related microRNAs based on gene expression data , 2015, Bioinform..
[29] Roded Sharan,et al. Associating Genes and Protein Complexes with Disease via Network Propagation , 2010, PLoS Comput. Biol..
[30] Yu-mei Rao 饶玉梅,et al. MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells , 2013, Journal of Huazhong University of Science and Technology [Medical Sciences].
[31] A. Stegh. Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils , 2012, Expert opinion on therapeutic targets.
[32] D. Fishman,et al. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition , 2014, Nature Communications.
[33] Udo Schumacher,et al. Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds , 2013, Molecular Cancer.
[34] Xing Chen,et al. Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.
[35] Gonzalo Vicente,et al. Expression of MicroRNA-15b and the Glycosyltransferase GCNT3 Correlates with Antitumor Efficacy of Rosemary Diterpenes in Colon and Pancreatic Cancer , 2014, PloS one.
[36] Xu Ma,et al. MiR‐185 is involved in human breast carcinogenesis by targeting Vegfa , 2014, FEBS letters.
[37] K. Aihara,et al. A discriminative approach for identifying domain–domain interactions from protein–protein interactions , 2010, Proteins.
[38] Bing Shi,et al. TAM: A method for enrichment and depletion analysis of a microRNA category in a list of microRNAs , 2010, BMC Bioinformatics.
[39] Marta Hoffmann,et al. Bisphenol A induce ovarian cancer cell migration via the MAPK and PI3K/Akt signalling pathways. , 2014, Toxicology letters.
[40] Hsien-Da Huang,et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions , 2013, Nucleic Acids Res..
[41] Christina Backes,et al. GeneTrail—advanced gene set enrichment analysis , 2007, Nucleic Acids Res..
[42] Ujjwal Maulik,et al. Development of the human cancer microRNA network , 2010 .
[43] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[44] Rui Jiang,et al. Comparative study of network-based prioritization of protein domains associated with human complex diseases , 2010 .
[45] Yadong Wang,et al. miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..
[46] Taichi Isobe,et al. miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway , 2014, eLife.
[47] C. Lindley,et al. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. , 2006, Clinical therapeutics.
[48] M. Byrom,et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.
[49] L. Meng,et al. miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1 , 2013, Oncology letters.
[50] Zhaolei Zhang,et al. Evidence for Positive Selection on a Number of MicroRNA Regulatory Interactions during Recent Human Evolution , 2012, PLoS genetics.